financetom
Business
financetom
/
Business
/
Winmark Shares Fall After Unchanged Q2 Earnings, Lower Revenue
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Winmark Shares Fall After Unchanged Q2 Earnings, Lower Revenue
Jul 17, 2024 9:12 AM

11:45 AM EDT, 07/17/2024 (MT Newswires) -- Winmark ( WINA ) shares fell 2% in recent trading Wednesday after reporting flat earnings in Q2 and a decline in revenue compared with the same period a year earlier.

The company reported Q2 earnings of $2.85 per diluted share, unchanged from a year earlier.

A single analyst polled by Capital IQ expected $2.77.

Revenue for the quarter ended June 29 to fell to $20.1 million from $20.4 million a year earlier.

A single analyst surveyed by Capital IQ expected $20.2 million.

Price: 414.67, Change: -8.33, Percent Change: -1.97

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-House Of Doge Says Will List On Nasdaq Through Merger With Brag House Holdings
BRIEF-House Of Doge Says Will List On Nasdaq Through Merger With Brag House Holdings
Oct 13, 2025
Oct 13 (Reuters) - House Of Doge: * HOUSE OF DOGE, THE CORPORATE ARM OF THE DOGECOIN FOUNDATION, TO LIST ON NASDAQ THROUGH MERGER WITH BRAG HOUSE HOLDINGS, INC. * HOUSE OF DOGE: BRAG HOUSE EXPECTED TO ISSUE ABOUT 594 MILLION SHARES OF COMMON STOCK, SOME OTHER SECURITIES CONVERTIBLE INTO ABOUT 69.3 MILLION * HOUSE OF DOGE- HOUSE OF DOGE...
Precigen Says Drug for Rare Respiratory Disease Shows Durable Outcomes
Precigen Says Drug for Rare Respiratory Disease Shows Durable Outcomes
Oct 13, 2025
08:07 AM EDT, 10/13/2025 (MT Newswires) -- Precigen ( PGEN ) said Monday that follow-up data from a clinical study showed durable outcomes in 83% of adult recurrent respiratory papillomatosis patients treated with its drug Papzimeos. The company said 15 out of the 18 complete responders in the study that supported the drug's US Food and Drug Administration approval showed...
Beyond Meat slumps after early settlement of convertible debt exchange offer
Beyond Meat slumps after early settlement of convertible debt exchange offer
Oct 13, 2025
(Reuters News) -Shares of Beyond Meat ( BYND ) tumbled more than 60% on Monday after the plant-based meat maker announced an early settlement of an exchange offer for convertible bonds as it seeks to reduce debt following years of struggling sales. Nearly 97% of its bondholders agreed to swap their old debt for new notes and shares, the company said...
Navan Submits Updated Nasdaq IPO Filing, Expects $24 to $26 a Share
Navan Submits Updated Nasdaq IPO Filing, Expects $24 to $26 a Share
Oct 13, 2025
08:07 AM EDT, 10/13/2025 (MT Newswires) -- Navan (NAVN) said in an updated regulatory filing with the US Securities and Exchange Commission Friday it plans to offer 30 million of its Class A common shares in an initial public offering, with the expected price between $24 and $26 per share. The selling shareholders are also offering an additional 6.9 million...
Copyright 2023-2026 - www.financetom.com All Rights Reserved